|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 38/00 | |||
| A61K 38/10 | |||
| A61K 39/00 |
| (11) | Patento numeris | 3233104 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15871075.6 |
| Europos patento paraiškos padavimo data | 2015-12-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/066400 |
| Data | 2015-12-17 |
| (87) | Numeris | WO 2016/100679 |
| Data | 2016-06-23 |
| (30) | Numeris | Data | Šalis |
| 201462094944 P | 2014-12-19 | US |
| (72) |
EGGINK, Laura L., US
HOOBER, J. Kenneth, US
|
| (73) |
Susavion Biosciences, Inc.,
1615 W. University Drive, Suite 132, Tempe, AZ 85281,
US
|
| (54) | IMMUNOTHERAPY TREATMENTS AND COMPOSITIONS |
| IMMUNOTHERAPY TREATMENTS AND COMPOSITIONS |